Inventor · disambiguated record
Katherine Harris
Also filed as: HARRIS KATHERINE · HARRIS KATHERINE E
12 granted patents·23 pending applications·43 citations·filing 2017–2025
89Inventor score
Top patents by PatentIndex Score
35 records- 0194US11186639B2Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2021·Granted Nov 30, 2021·7 cites·20 claims
- 0293US11421027B2CD3 binding antibodiesTENEOONE INC·Filed 2021·Granted Aug 23, 2022·6 cites·17 claims
- 0393US11390681B2Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOTWO INC·Filed 2021·Granted Jul 19, 2022·8 cites·20 claims
- 0492US11505606B2CD3 binding antibodiesTENEOBIO INC·Filed 2017·Granted Nov 22, 2022·10 cites·30 claims
- 0587US12037407B2Immune cells having co-expressed shRNAS and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2023·Granted Jul 16, 2024·2 cites·71 claims
- 0686US11613572B2CD3 binding antibodiesTENEOBIO INC·Filed 2017·Granted Mar 28, 2023·4 cites·13 claims
- 0786US11434299B2Anti-BCMA heavy chain-only antibodiesTENEOBIO INC·Filed 2017·Granted Sep 6, 2022·4 cites·17 claims
- 0884US11884735B2Agonistic anti-IL-2R antibodies and methods of useTENEOBIO INC·Filed 2023·Granted Jan 30, 2024·2 cites·25 claims
- 0983US2025066476A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2023·Application pending·0 cites
- 1079US2023272075A1Cd3 binding antibodiesTENEOBIO INC·Filed 2022·Application pending·0 cites
- 1177US2025340638A1Cd3 binding antibodiesTENEOONE INC·Filed 2025·Application pending·0 cites
- 1277US2023082151A1Cd3 binding antibodiesTENEOONE INC·Filed 2022·Application pending·0 cites
- 1376US12371505B2Anti-BCMA heavy chain-only antibodiesTENEOBIO INC·Filed 2022·Granted Jul 29, 2025·0 cites·10 claims
- 1474US2022332820A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2021·Application pending·0 cites
- 1572US2024309106A1Immune cells having co-expressed shrnas and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1672US2023203161A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOBIO INC·Filed 2021·Application pending·0 cites
- 1771US2024124599A1Anti-bcma heavy chain-only antibodiesTENEOBIO INC·Filed 2023·Application pending·0 cites
- 1868US2024018235A1Cd3 binding antibodiesTENEOBIO INC·Filed 2023·Application pending·0 cites
- 1967US2024117046A1Heavy chain antibodies binding to cd22TENEOBIO INC·Filed 2023·Application pending·0 cites
- 2065US2025270337A1Anti-bcma heavy chain-only antibodiesTENEOBIO INC·Filed 2025·Application pending·0 cites
- 2165US2024117063A1Anti-cd20 antibodies and car-t structuresTENEOBIO INC·Filed 2023·Application pending·0 cites
- 2265US2024042032A1Anti-cd19 antibodies and car-t structuresTENEOBIO INC·Filed 2023·Application pending·0 cites
- 2361US2025346682A1Anti-cd20 antibodies and car-t structuresTENEOBIO INC·Filed 2025·Application pending·0 cites
- 2460US12202898B2Heavy chain antibodies binding to CD19TENEOTWO INC·Filed 2019·Granted Jan 21, 2025·0 cites·39 claims
- 2560US2025250350A1Immune cells having co-expressed shrnas and logic gate systemsArsenal Biosciences·Filed 2025·Application pending·0 cites
- 2659US11970540B2Anti-BCMA heavy chain-only antibodiesTENEOBIO INC·Filed 2018·Granted Apr 30, 2024·0 cites·14 claims
- 2757US11873336B2Heavy chain antibodies binding to CD22TENEOBIO INC·Filed 2018·Granted Jan 16, 2024·0 cites·14 claims
- 2856US2025367237A1C-kit binding proteins, chimeric antigen receptors, and uses thereofTENEOBIO INC·Filed 2025·Application pending·0 cites
- 2955US2024002498A1Heavy chain antibodies binding to folate receptor alphaTENEOBIO INC·Filed 2021·Application pending·0 cites
- 3055US2024226162A9Anti-psma antibodies and car-t structuresTENEOBIO INC·Filed 2022·Application pending·0 cites
- 3155US2023257473A1Multi-specific antibodies binding to bcmaTENEOBIO INC·Filed 2021·Application pending·0 cites
- 3252US2023036213A1T-cell epitopes of human parainfluenza virus 3 for adoptive t-cell immunotherapyCHILDRENS NAT MEDICAL CT·Filed 2020·Application pending·0 cites
- 3350US2020138865A1Anti-b-cell maturation antigen chimeric antigen receptors with human domainsUS HEALTH·Filed 2018·Application pending·0 cites
- 3450US2023192843A1Mesothelin binding proteins and uses thereofTENEOBIO INC·Filed 2022·Application pending·0 cites
- 3550US2024182597A1Anti-muc1-c antibodies and car-t structuresTENEOBIO INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katherine Harris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →